Shenzhen Weiguang Biological Products Co., Ltd.
SZSE:002880.SZ
33.35 (CNY) • At close October 26, 2023
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| 217.545 | 121.121 | 204.992 | 189.585 | 171.152 | 156.637 | 154.749 | 153.227 | 124.855 | 100.542 | 88.881 | 71.445 |
| Afschrijvingen & Amortisatie
| 87.309 | 65.258 | 55.484 | 45.723 | 39.789 | 41.826 | 41.594 | 40.079 | 40.069 | 39.184 | 29.717 | 15.718 |
| Uitgestelde Inkomstenbelasting
| -7.041 | 0.415 | 1.102 | 0.405 | 0.29 | -1.054 | -1.133 | 0.109 | -0.279 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| 66.231 | -169.958 | -19.123 | 67.716 | -29.544 | -104.73 | -182.828 | -85.079 | -39.995 | -30.744 | -108.056 | 14.304 |
| Vorderingen
| 88.21 | 33.523 | -2.722 | -15.571 | -61.715 | -82.374 | -81.606 | -5.338 | -1.524 | 4.927 | -3.939 | 41.281 |
| Voorraden
| -50.56 | -183.834 | -37.755 | 83.802 | 28.27 | -53.749 | -86.197 | -85.027 | -31.085 | -27.56 | -76.517 | -41.16 |
| Crediteuren
| 35.623 | -20.062 | 20.252 | -0.921 | 3.611 | 32.447 | -13.892 | 5.177 | -7.108 | 0 | 0 | 0 |
| Overig Werkkapitaal
| 20.86 | 0.415 | 1.102 | 0.405 | 0.29 | -50.981 | -96.631 | -0.052 | -8.91 | -3.184 | -31.539 | 55.465 |
| Overige Niet-Contante Posten
| 16.922 | -15.222 | 5.533 | 0.934 | 4.304 | 5.807 | 15.099 | 18.179 | 25.161 | 25.185 | 10.388 | 14.413 |
| Kasstroom uit Operationele Activiteiten
| 397.939 | 1.199 | 246.887 | 303.958 | 185.701 | 99.54 | 28.614 | 126.406 | 150.09 | 134.166 | 20.929 | 115.88 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -328.854 | -327.373 | -240.827 | -189.193 | -77.794 | -84.512 | -61.361 | -59.911 | -85.864 | -38.375 | -56.928 | -172.948 |
| Netto Overnames
| -22.386 | 0.117 | 0.23 | 20.605 | 3.303 | 0.003 | 0.087 | 0.008 | 0.09 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -1 | -0.117 | -49.48 | -14 | -4.95 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 1.106 | -0.23 | -20.605 | -3.303 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 0 | -160.992 | 0.23 | 0.605 | -17.898 | 4.652 | 0.797 | 4.608 | 3.934 | 7.187 | 7.728 | 41.604 |
| Kasstroom uit Investeringsactiviteiten
| -352.167 | -487.259 | -290.077 | -202.588 | -100.642 | -79.859 | -60.564 | -55.303 | -81.93 | -31.188 | -49.2 | -131.344 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| -21.159 | -25 | -132 | -178 | -29 | -101 | -476.825 | -317.55 | -348.7 | -364.5 | -230.625 | -200 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -45.36 | -45.36 | -40.5 | -35.683 | -32.538 | -57.335 | -94.017 | -58.802 | -69.429 | -37.321 | -125.669 | -110.412 |
| Overige Financieringsactiviteiten
| -1.42 | 530.588 | 77.647 | 279.208 | 21.201 | 60 | 879.855 | 265.93 | 337.662 | 342 | 315 | 355 |
| Kasstroom uit Financieringsactiviteiten
| -88.18 | 447.903 | -96.175 | 65.525 | -40.337 | -98.335 | 309.012 | -110.422 | -80.467 | -59.821 | -41.294 | 44.588 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -42.408 | -38.157 | -139.365 | 166.895 | 44.723 | -78.654 | 277.063 | -39.32 | -12.307 | 43.157 | -69.565 | 29.124 |
| Kaspositie aan het Einde van de Periode
| 251.445 | 293.853 | 332.01 | 471.375 | 304.48 | 259.757 | 338.411 | 61.348 | 100.668 | 112.974 | 69.818 | 139.383 |